| Schedule of condensed consolidated balance Sheet |
| Condensed Consolidated Balance Sheet as of September 30, 2021 |
|
As
Previously Reported |
|
|
Adjustment |
|
|
As Restated |
|
| Additional paid-in capital |
|
$ |
671,906 |
|
|
$ |
4,362 |
|
|
$ |
676,268 |
|
| Accumulated deficit |
|
$ |
(429,855 |
) |
|
$ |
(4,362 |
) |
|
$ |
(434,217 |
) |
|
| Schedule of condensed consolidated statement of operations |
| Condensed Consolidated Statement of Operations for the Three Months Ended September 30, 2021 |
|
As
Previously
Reported |
|
|
Adjustment |
|
|
As Restated |
|
| |
|
(amounts in thousands except share and per share amounts) |
|
| Change in fair value of warrant liability |
|
$ |
(6,551 |
) |
|
$ |
12,046 |
|
|
$ |
5,495 |
|
| Change in fair value of subordinated convertible notes |
|
$ |
- |
|
|
$ |
(7,684 |
) |
|
$ |
(7,684 |
) |
| Total operating expenses |
|
$ |
64,504 |
|
|
$ |
4,362 |
|
|
$ |
68,866 |
|
| Net loss before income taxes |
|
$ |
(20,284 |
) |
|
$ |
(4,362 |
) |
|
$ |
(24,646 |
) |
| Net loss |
|
$ |
(20,283 |
) |
|
$ |
(4,362 |
) |
|
$ |
(24,645 |
) |
| Net income attributable to common shareholders |
|
$ |
28,663 |
|
|
$ |
(4,362 |
) |
|
$ |
23,401 |
|
| Net income per share, basic |
|
$ |
0.46 |
|
|
$ |
(0.07 |
) |
|
$ |
0.39 |
|
| Net income per share, diluted |
|
$ |
0.46 |
|
|
$ |
(0.33 |
) |
|
$ |
0.13 |
|
| Weighted average shares used in computing net loss per share, diluted |
|
|
62,314,396 |
|
|
|
156,799,692 |
|
|
|
219,114,088 |
|
| Condensed Consolidated Statement of Operations for the Nine Months Ended September 30, 2021 |
|
As
Previously
Reported |
|
Adjustment |
|
As Restated |
| |
|
(amounts in thousands except per share amounts) |
| Change in fair value of warrant liability |
|
$ |
42,239 |
|
|
$ |
12,046 |
|
|
$ |
54,285 |
|
| Change in fair value of subordinated convertible notes |
|
$ |
49,561 |
|
|
$ |
(7,684 |
) |
|
$ |
41,877 |
|
| Total operating expenses |
|
$ |
248,386 |
|
|
$ |
4,362 |
|
|
$ |
252,748 |
|
| Net loss before income taxes |
|
$ |
(132,837 |
) |
|
$ |
(4,362 |
) |
|
$ |
(137,199 |
) |
| Net loss |
|
$ |
(132,878 |
) |
|
$ |
(4,362 |
) |
|
$ |
(137,240 |
) |
| Net income attributable to common shareholders |
|
$ |
(99,514 |
) |
|
$ |
(4,362 |
) |
|
$ |
(103,876 |
) |
| Net income per share, basic and diluted |
|
$ |
(1.87 |
) |
|
$ |
(0.09 |
) |
|
$ |
(1.96 |
) |
|
| Schedule of condensed consolidated statement of cash flows |
| Condensed Consolidated Statement of Cash Flows for the Nine Months Ended September 30, 2021 |
|
As
Previously
Reported |
|
|
Adjustment |
|
|
As Restated |
|
| Net loss |
|
$ |
(132,878 |
) |
|
$ |
(4,362 |
) |
|
$ |
(137,240 |
) |
| Change in fair value of warrants |
|
$ |
42,239 |
|
|
$ |
12,046 |
|
|
$ |
54,285 |
|
| Change in fair value of subordinated convertible notes |
|
$ |
49,561 |
|
|
$ |
(7,684 |
) |
|
$ |
41,877 |
|
| Issuance of common stock related to convertible debt |
|
$ |
100,311 |
|
|
$ |
(7,684 |
) |
|
$ |
92,627 |
|
| Issuance of common stock related to warrants exercised |
|
$ |
73,456 |
|
|
$ |
12,046 |
|
|
$ |
85,502 |
|
|